Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04141 (
granulocyte-macrophage colony-stimulating factor
)
6,790
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
STAM1
, a member of the STAM (signal transducing adapter molecule) family, has a unique structure containing a Src homology 3 domain and ITAM (immunoreceptor tyrosine-based activation motif).
STAM1
was previously shown to be associated with the Jak2 and Jak3 tyrosine kinases and to be involved in the regulation of intracellular signal transduction mediated by interleukin-2 (IL-2) and
granulocyte-macrophage colony-stimulating factor
(
GM-CSF
) in vitro. Here we generated mice lacking
STAM1
by using homologous recombination with embryonic stem cells.
STAM1
(-/-) mice were morphologically indistinguishable from their littermates at birth. However, growth retardation in the third week after birth was observed for the
STAM1
(-/-) mice. Unexpectedly, despite the absence of
STAM1
, hematopoietic cells, including T- and B-lymphocyte and other hematopoietic cell populations, developed normally and responded well to several cytokines, including IL-2 and
GM-CSF
. However, histological analyses revealed the disappearance of hippocampal CA3 pyramidal neurons in
STAM1
(-/-) mice. Furthermore, we observed that primary hippocampal neurons derived from
STAM1
(-/-) mice are vulnerable to cell death induced by excitotoxic amino acids or an NO donor. These data suggest that
STAM1
is dispensable for cytokine-mediated signaling in lymphocytes but may be involved in the survival of hippocampal CA3 pyramidal neurons.
...
PMID:Loss of hippocampal CA3 pyramidal neurons in mice lacking STAM1. 1134 Jan 72
AMSH, a molecule that associates with
STAM1
, is involved in the in vitro cell growth signaling mediated by interleukin 2 and
granulocyte-macrophage colony-stimulating factor
. To investigate the in vivo functional role of AMSH, we have generated AMSH-deficient mice by gene targeting. The AMSH-deficient mice were morphologically indistinguishable from their littermates at birth, and histopathological examinations revealed normal morphogenesis in all tissues tested. However, all the AMSH-deficient mice exhibited postnatal growth retardation and died between postnatal day 19 (P19) and P23. Examination of brain sections at P6 demonstrated significant loss of neurons and apoptotic cells in the CA1 subfield of the hippocampus. Brain atrophy developed by P16 and was accompanied by complete loss of the CA1 neurons in the hippocampus and marked atrophy of the cerebral cortex. Furthermore, AMSH-deficient hippocampal neuronal cells were unable to survive in vitro, even in the presence of several stimulatory cytokines, while AMSH-deficient cerebellar neurons, thymocytes, and embryonic fibroblasts survived normally. Taken together, these observations indicate that AMSH is an essential molecule for the survival of neuronal cells in early postnatal mice.
...
PMID:Loss of neurons in the hippocampus and cerebral cortex of AMSH-deficient mice. 1171 95